Jefferies Group's ROIV Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 7,266 shares of Roivant Sciences Ltd. (ROIV) worth $201,268, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in ROIV, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 3.51 M shares. Largest reduction occurred in Q1 2026, reducing 3.51 M shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Roivant Sciences (ROIV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Roivant Sciences (ROIV) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -3.51 M | Reduce 99.79% | 7,266 | $27.70 |
| Q4 2025 | +3.51 M | New Buy | 3.51 M | $21.70 |
| Q1 2025 | -40,000 | Sold Out | 0 | $0.00 |
| Q4 2024 | +40,000 | New Buy | 40,000 | $11.83 |
| Q3 2024 | -132,500 | Sold Out | 0 | $0.00 |
| Q2 2024 | +132,500 | New Buy | 132,500 | $10.57 |
| Q3 2023 | -50,000 | Sold Out | 0 | $0.00 |
| Q2 2023 | -12,500 | Reduce 20.00% | 50,000 | $10.08 |
| Q1 2023 | +62,500 | New Buy | 62,500 | $7.38 |
Jefferies Group's Roivant Sciences Investment FAQs
Jefferies Group first purchased Roivant Sciences Ltd. (ROIV) in Q1 2023, acquiring 62,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Roivant Sciences Ltd. (ROIV) for 9 quarters since Q1 2023.
Jefferies Group's largest addition to Roivant Sciences Ltd. (ROIV) was in Q4 2025, adding 3,514,833 shares worth $76.27 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 7,266 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $201,268.
As of the Q1 2026 filing, Roivant Sciences Ltd. (ROIV) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Roivant Sciences Ltd. (ROIV) was 3,514,833 shares, as reported at the end of Q4 2025.